SiliconInvestor
     Advanced Search   [ sign in ]

register
Sponsor		  register
Register

 Biotech / Medical : NKTR Drug delivery Company

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: idos who wrote (346)3/15/2011 7:15:23 PM
From: ghmmRead Replies (2) of 389
 
Anyone have thoughts on the Phase 2 Ovarian data seen thus-far? I hope I am wrong but don't see the data being strong enough for a single arm accelerated approval. I was trying to speculate if the company possibly expanded enrollment for another reason (get more data to go into Phase 3, attract a partner) but I think they are really shooting for the accelerated approval. If anyone has links to studies/meta analysis of this patient population would appreciate any links.
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.